Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Invested Capital (2016 - 2025)

Historic Invested Capital for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $72.5 million.

  • Editas Medicine's Invested Capital fell 5870.85% to $72.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.5 million, marking a year-over-year decrease of 5870.85%. This contributed to the annual value of $191.7 million for FY2024, which is 4508.46% down from last year.
  • Per Editas Medicine's latest filing, its Invested Capital stood at $72.5 million for Q3 2025, which was down 5870.85% from $75.9 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Invested Capital ranged from a high of $638.0 million in Q1 2021 and a low of $72.5 million during Q3 2025
  • In the last 5 years, Editas Medicine's Invested Capital had a median value of $360.5 million in 2023 and averaged $354.3 million.
  • Per our database at Business Quant, Editas Medicine's Invested Capital surged by 17198.88% in 2021 and then plummeted by 6730.34% in 2025.
  • Over the past 5 years, Editas Medicine's Invested Capital (Quarter) stood at $553.6 million in 2021, then crashed by 34.85% to $360.7 million in 2022, then fell by 3.21% to $349.1 million in 2023, then plummeted by 45.08% to $191.7 million in 2024, then crashed by 62.17% to $72.5 million in 2025.
  • Its Invested Capital stands at $72.5 million for Q3 2025, versus $75.9 million for Q2 2025 and $117.0 million for Q1 2025.